Revealing the HIV-1 Interactome

揭示 HIV-1 相互作用组

基本信息

  • 批准号:
    7685768
  • 负责人:
  • 金额:
    $ 45.63万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2009
  • 资助国家:
    美国
  • 起止时间:
    2009-02-15 至 2014-01-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Given the limited genetic coding capacity of HIV-1, it is reasonable to expect that the virus must interact with an extensive battery of cellular factors to complete its passage through the cell. Indeed, it is remarkable that the viral genome, comprising only about 0.0003% of the entire genetic capacity of the cell, commandeers the cellular environment to its own advantage. However, to date and despite being easily the most studied virus, only a relatively small group of cellular proteins have been shown essential for HIV-1 propagation. A genetic/proteomic approach has been developed that utilizes a random mutagenic protocol followed by a stringent step of biological selection in efforts to pinpoint those rare sites within the HIV-1 proteome that can accommodate the incorporation of a potent affinity tag without significant loss of those structure/function relationships that are required for viral replication-competency. In conjunction with a novel cryogenic methodology to capture and preserve transient viral-host interactions during immunoisolation, we have recovered several host proteins in association with the replicating virus but previously obscured from conventional scientific investigation. We are reassured that our method is sound since among the cellular proteins recovered and identified using our methodologies are those previously determined by other groups to interact with HIV-1. Furthermore, a straightforward mass spectrometric technique is presented that discriminates with high accuracy between specific and nonspecific proteins in immunoisolated protein complexes. The combined genetic and proteomic method described is a powerful tool set that can be utilized to identify cellular proteins in transient association with a given viral protein at points during the viral life cycle, a subset of which may be absolutely required by the virus for its livelihood but in part, dispensable by the host cell. PUBLIC HEALTH RELEVANCE: Given the known complexity of biological processes within the cell as well as the rigid constraints imposed by the small coding size of the HIV-1 genome, it is reasonable to expect that the HIV-1 proteome must rely upon a battery of host factor arrays to complete its intracellular tasks. In an effort to recover and identify requisite host proteins that interact in complex with the viral machinery, we have developed a systematic method to select derivatives that can encode a small, but potent, foreign epitope tag yet remain fully replication-competent in culture. In conjunction with a novel cryogenic methodology to capture and preserve transient viral-host interactions, we have recovered and identified new sets of host proteins existing at the viral/host interface (in association with HIV-1 but previously obscured from conventional scientific investigation), a subset of which may have the potential to provide a new targets for small molecule intervention against this virus.
描述(申请人提供):鉴于HIV-1的遗传编码能力有限,有理由预计该病毒必须与广泛的细胞因子相互作用才能完成细胞传递。事实上,值得注意的是,仅占细胞全部遗传能力约0.0003%的病毒基因组侵占了细胞环境,使之成为自己的优势。然而,到目前为止,尽管很容易成为研究最多的病毒,但只有相对较小的一组细胞蛋白被证明是HIV-1传播所必需的。已经开发出一种遗传/蛋白质组学方法,该方法利用随机诱变方案,然后经过严格的生物选择步骤,努力定位HIV-1蛋白质组中那些能够容纳有效亲和标签的稀有位置,而不会显著损失病毒复制能力所需的那些结构/功能关系。结合一种新的低温方法来捕获和保存免疫分离过程中的瞬时病毒-宿主相互作用,我们已经恢复了几种与复制病毒相关的宿主蛋白,但这些蛋白以前被传统的科学研究所掩盖。我们确信我们的方法是可靠的,因为在使用我们的方法恢复和鉴定的细胞蛋白中,有那些先前由其他小组确定的与HIV-1相互作用的蛋白。此外,还提出了一种简单的质谱学技术,该技术可以高精度地区分免疫分离蛋白复合体中的特定和非特定蛋白。所描述的遗传和蛋白质组相结合的方法是一套强大的工具,可用于在病毒生命周期的各个时间点识别与给定病毒蛋白瞬时相关的细胞蛋白,其中一部分可能是病毒赖以生存所必需的,但部分是宿主细胞所必需的。与公共卫生相关:鉴于细胞内生物过程的已知复杂性以及艾滋病毒-1基因组编码尺寸较小施加的严格限制,有理由预计艾滋病毒-1蛋白质组必须依赖一组宿主因子阵列来完成其细胞内任务。为了恢复和鉴定与病毒机制相互作用的必需宿主蛋白,我们开发了一种系统的方法来选择衍生物,这些衍生物可以编码一个小但有效的外源表位标签,但在培养中仍保持完全复制能力。结合一种新的低温方法来捕捉和保存瞬时的病毒-宿主相互作用,我们已经恢复和鉴定了存在于病毒/宿主界面的新的宿主蛋白集(与HIV-1相关,但以前被传统的科学研究所掩盖),其中的一个子集可能有可能为针对这种病毒的小分子干预提供新的靶点。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

MARK AYER MUESING其他文献

MARK AYER MUESING的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('MARK AYER MUESING', 18)}}的其他基金

Maturational Intermediates of Trimeric HIV-1 Envelope as Unique Immunogens
三聚体 HIV-1 包膜的成熟中间体作为独特的免疫原
  • 批准号:
    8790245
  • 财政年份:
    2014
  • 资助金额:
    $ 45.63万
  • 项目类别:
HOST INTERACTIONS OF GENE PRODUCTS FROM HIV-1
HIV-1 基因产物的宿主相互作用
  • 批准号:
    8361508
  • 财政年份:
    2011
  • 资助金额:
    $ 45.63万
  • 项目类别:
HOST INTERACTIONS OF GENE PRODUCTS FROM HIV-1
HIV-1 基因产物的宿主相互作用
  • 批准号:
    8169125
  • 财政年份:
    2010
  • 资助金额:
    $ 45.63万
  • 项目类别:
Revealing the HIV-1 Interactome
揭示 HIV-1 相互作用组
  • 批准号:
    8415922
  • 财政年份:
    2009
  • 资助金额:
    $ 45.63万
  • 项目类别:
Revealing the HIV-1 Interactome
揭示 HIV-1 相互作用组
  • 批准号:
    8016699
  • 财政年份:
    2009
  • 资助金额:
    $ 45.63万
  • 项目类别:
Revealing the HIV-1 Interactome
揭示 HIV-1 相互作用组
  • 批准号:
    8211020
  • 财政年份:
    2009
  • 资助金额:
    $ 45.63万
  • 项目类别:
HOST INTERACTIONS OF GENE PRODUCTS FROM HIV-1
HIV-1 基因产物的宿主相互作用
  • 批准号:
    7954081
  • 财政年份:
    2009
  • 资助金额:
    $ 45.63万
  • 项目类别:
Revealing the HIV-1 Interactome
揭示 HIV-1 相互作用组
  • 批准号:
    7916902
  • 财政年份:
    2009
  • 资助金额:
    $ 45.63万
  • 项目类别:
Revealing the HIV-1 Interactome
揭示 HIV-1 相互作用组
  • 批准号:
    7766256
  • 财政年份:
    2009
  • 资助金额:
    $ 45.63万
  • 项目类别:
HIV INTEGRASE SH3 INTERACTIONS
HIV 整合酶 SH3 相互作用
  • 批准号:
    7722234
  • 财政年份:
    2008
  • 资助金额:
    $ 45.63万
  • 项目类别:

相似国自然基金

Neo-antigens暴露对肾移植术后体液性排斥反应的影响及其机制研究
  • 批准号:
    2022J011295
  • 批准年份:
    2022
  • 资助金额:
    10.0 万元
  • 项目类别:
    省市级项目
结核分枝杆菌持续感染期抗原(latency antigens)的重组BCG疫苗研究
  • 批准号:
    30801055
  • 批准年份:
    2008
  • 资助金额:
    19.0 万元
  • 项目类别:
    青年科学基金项目

相似海外基金

Bovine herpesvirus 4 as a vaccine platform for African swine fever virus antigens in pigs
牛疱疹病毒 4 作为猪非洲猪瘟病毒抗原的疫苗平台
  • 批准号:
    BB/Y006224/1
  • 财政年份:
    2024
  • 资助金额:
    $ 45.63万
  • 项目类别:
    Research Grant
A novel vaccine approach combining mosquito salivary antigens and viral antigens to protect against Zika, chikungunya and other arboviral infections.
一种结合蚊子唾液抗原和病毒抗原的新型疫苗方法,可预防寨卡病毒、基孔肯雅热和其他虫媒病毒感染。
  • 批准号:
    10083718
  • 财政年份:
    2023
  • 资助金额:
    $ 45.63万
  • 项目类别:
    Small Business Research Initiative
Uncovering tumor specific antigens and vulnerabilities in ETP-acute lymphoblastic leukemia
揭示 ETP-急性淋巴细胞白血病的肿瘤特异性抗原和脆弱性
  • 批准号:
    480030
  • 财政年份:
    2023
  • 资助金额:
    $ 45.63万
  • 项目类别:
    Operating Grants
Regulation of B cell responses to vaccines by long-term retention of antigens in germinal centres
通过在生发中心长期保留抗原来调节 B 细胞对疫苗的反应
  • 批准号:
    MR/X009254/1
  • 财政年份:
    2023
  • 资助金额:
    $ 45.63万
  • 项目类别:
    Research Grant
Adaptive Discrimination of Risk of Antigens in Immune Memory Dynamics
免疫记忆动态中抗原风险的适应性辨别
  • 批准号:
    22KJ1758
  • 财政年份:
    2023
  • 资助金额:
    $ 45.63万
  • 项目类别:
    Grant-in-Aid for JSPS Fellows
22-ICRAD Call 2 - Improving the diagnosis of tuberculosis in domestic ruminants through the use of new antigens and test platforms
22-ICRAD 呼吁 2 - 通过使用新抗原和测试平台改善家养反刍动物结核病的诊断
  • 批准号:
    BB/Y000927/1
  • 财政年份:
    2023
  • 资助金额:
    $ 45.63万
  • 项目类别:
    Research Grant
Protective immunity elicited by distinct polysaccharide antigens of classical and hypervirulent Klebsiella
经典和高毒力克雷伯氏菌的不同多糖抗原引发的保护性免疫
  • 批准号:
    10795212
  • 财政年份:
    2023
  • 资助金额:
    $ 45.63万
  • 项目类别:
Integrative proteome analysis to harness humoral immune response against tumor antigens
综合蛋白质组分析利用针对肿瘤抗原的体液免疫反应
  • 批准号:
    23K18249
  • 财政年份:
    2023
  • 资助金额:
    $ 45.63万
  • 项目类别:
    Grant-in-Aid for Challenging Research (Exploratory)
Functionally distinct human CD4 T cell responses to novel evolutionarily selected M. tuberculosis antigens
功能独特的人类 CD4 T 细胞对新型进化选择的结核分枝杆菌抗原的反应
  • 批准号:
    10735075
  • 财政年份:
    2023
  • 资助金额:
    $ 45.63万
  • 项目类别:
Targeting T3SA proteins as protective antigens against Yersinia
将 T3SA 蛋白作为针对耶尔森氏菌的保护性抗原
  • 批准号:
    10645989
  • 财政年份:
    2023
  • 资助金额:
    $ 45.63万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了